Screener
Moderna MRNA Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Moderna’s reported figures.
The source filing: Moderna’s 8-K, filed July 31, 2026. Open the filing →
- Filed
- Jul 31, 2026, 7:03 AM EDT
- Accession
- 0001682852-26-000147
FAQ
- What is Moderna's enterprise value?
- Moderna (MRNA) reported enterprise value of $27.3B in Q2 2026.
- How has Moderna's enterprise value changed year-over-year?
- Moderna's enterprise value increased by 177.1% year-over-year, from $9.85B to $27.3B.
- What is the long-term trend for Moderna's enterprise value?
- Over 5 years (2020 to 2025), Moderna's enterprise value has grown at a -23.8% compound annual growth rate (CAGR), from $39.98B to $10.26B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about Moderna's enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude